Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.200
-0.010 (-0.83%)
At close: Feb 11, 2026, 4:00 PM EST
1.200
0.00 (0.00%)
Pre-market: Feb 12, 2026, 4:52 AM EST
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $165.22 million as of February 12, 2026. Its market cap has increased by 231.39% in one year.
Market Cap
165.22M
Enterprise Value
141.18M
1-Year Change
231.39%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $165.22M, a decrease of -67.86%. That is a compound annual growth rate of -23.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 165.22M | 10.09% |
| Dec 31, 2025 | 150.07M | 230.61% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SANUWAVE Health | 224.01M |
| CVRx, Inc. | 180.06M |
| Rapid Micro Biosystems | 177.29M |
| Nano-X Imaging | 171.99M |
| Apyx Medical | 165.76M |
| Inogen | 158.28M |
| InfuSystem Holdings | 153.94M |
| LENSAR | 150.50M |